Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
gastric-cancer
esophagogastric junction adenocarcinoma, gastric adenocarcinoma, esophageal adenocarcinoma, resectable esophagogastric adenocarcinoma, neoadjuvant therapy, gastric cancer, flot, tislelizumab, neoadjuvant, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 892009
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.